Angiogenesis induced by tumor necrosis factor-agr; is mediated by α4 integrins
dc.contributor.author | Vanderslice, Peter | en_US |
dc.contributor.author | Munsch, Christy L. | en_US |
dc.contributor.author | Rachal, Eugene | en_US |
dc.contributor.author | Erichsen, David | en_US |
dc.contributor.author | Sughrue, Kay M. | en_US |
dc.contributor.author | Truong, Ann N. | en_US |
dc.contributor.author | Wygant, James N. | en_US |
dc.contributor.author | McIntyre, Bradley W. | en_US |
dc.contributor.author | Eskin, Suzanne G. | en_US |
dc.contributor.author | Tilton, Ronald G. | en_US |
dc.contributor.author | Polverini, Peter J. | en_US |
dc.date.accessioned | 2006-09-08T19:36:33Z | |
dc.date.available | 2006-09-08T19:36:33Z | |
dc.date.issued | 1998-05 | en_US |
dc.identifier.citation | Vanderslice, Peter; Munsch, Christy L.; Rachal, Eugene; Erichsen, David; Sughrue, Kay M.; Truong, Ann N.; Wygant, James N.; McIntyre, Bradley W.; Eskin, Suzanne G.; Tilton, Ronald G.; Polverini, Peter J.; (1998). "Angiogenesis induced by tumor necrosis factor-agr; is mediated by α4 integrins." Angiogenesis 2(3): 265-275. <http://hdl.handle.net/2027.42/41761> | en_US |
dc.identifier.issn | 0969-6970 | en_US |
dc.identifier.issn | 1573-7209 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41761 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14517466&dopt=citation | en_US |
dc.description.abstract | Tumor necrosis factor-α (TNF-α) and fibroblast growth factor-2 (FGF-2 or bFGF) are potent stimulators of angiogenesis. TNF-α, but not FGF-2, can induce the expression of vascular cell adhesion molecule-1 (VCAM-1) on the surface of endothelial cells. The soluble form of VCAM-1 has recently been demonstrated to function as an angiogenic mediator. Here we demonstrate that monoclonal antibodies directed against VCAM-1 or its α4 integrin counter-receptor inhibited TNF-α-induced endothelial cell migration in vitro. Angiogenesis induced in vivo in rat corneas by TNF-α was inhibited by a neutralizing antibody directed against the rat α4 integrin subunit. A peptide antagonist of the a4 integrins blocked TNF-α-induced endothelial cell migration in vitro and angiogenesis in rat corneas in vivo. No inhibition by the antibodies or peptide antagonist was observed either in vitro or in vivo when FGF-2 was used as the stimulus. The peptide antagonist did not inhibit TNF-a binding to its receptor nor did it block the function of αvβ3, an integrin previously implicated in TNF-a and FGF-2 mediated angiogenesis. These results demonstrate that angiogenic processes induced by TNF-α are mediated in part by agr;4 integrins possibly by a mechanism involving the induction of soluble VCAM-1. | en_US |
dc.format.extent | 190432 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Cardiology | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Ophthalmology | en_US |
dc.title | Angiogenesis induced by tumor necrosis factor-agr; is mediated by α4 integrins | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Oral Medicine, Pathology and Surgery, The University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Cell Biology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Cell Biology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationother | Department of Cell Biology, Texas Biotechnology Corporation, Houston, TX, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 14517466 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41761/1/10456_2004_Article_188219.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1009296700991 | en_US |
dc.identifier.source | Angiogenesis | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.